Drug Shortage Report for APO-CLINDAMYCIN
Report ID | 32520 |
Drug Identification Number | 02245233 |
Brand name | APO-CLINDAMYCIN |
Common or Proper name | CLINDAMYCIN |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | CLINDAMYCIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | J01FF |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-12-11 |
Estimated end date | 2018-02-15 |
Actual end date | 2018-01-25 |
Shortage status | Resolved |
Updated date | 2018-01-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-01-26 | French | Compare |
v6 | 2018-01-26 | English | Compare |
v5 | 2018-01-16 | French | Compare |
v4 | 2018-01-16 | English | Compare |
v3 | 2017-12-12 | French | Compare |
v2 | 2017-12-12 | English | Compare |
v1 | 2017-12-12 | English | Compare |
Showing 1 to 7 of 7